vs
雅保（ALB）与Astrana Health, Inc.（ASTH）财务数据对比。点击上方公司名可切换其他公司
雅保的季度营收约是Astrana Health, Inc.的1.5倍（$1.4B vs $950.5M），Astrana Health, Inc.净利率更高（0.7% vs -29.0%，领先29.7%），Astrana Health, Inc.同比增速更快（42.9% vs 15.9%），雅保自由现金流更多（$233.1M vs $-6.0M），过去两年Astrana Health, Inc.的营收复合增速更高（53.3% vs 2.4%）
雅保是全球知名的特种化学品企业，业务覆盖研发、生产与全球销售，下设锂、溴、催化剂三大板块。锂业务线供应碳酸锂、氢氧化锂、氯化锂等锂化合物及相关试剂，产品广泛应用于消费电子、电动汽车锂电池、高性能润滑脂、热塑性弹性体等领域。
Astrana Health是一家总部位于美国的价值导向型医疗服务提供商，主要服务全美符合联邦医保资格的老年群体，提供上门初级护理、慢性病管理及护理协调服务，致力于提升患者健康水平、降低不必要的医疗支出。
ALB vs ASTH — 直观对比
营收规模更大
ALB
是对方的1.5倍
$950.5M
营收增速更快
ASTH
高出27.0%
15.9%
净利率更高
ASTH
高出29.7%
-29.0%
自由现金流更多
ALB
多$239.1M
$-6.0M
两年增速更快
ASTH
近两年复合增速
2.4%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.4B | $950.5M |
| 净利润 | $-414.2M | $6.6M |
| 毛利率 | 13.9% | — |
| 营业利润率 | -15.2% | 1.9% |
| 净利率 | -29.0% | 0.7% |
| 营收同比 | 15.9% | 42.9% |
| 净利润同比 | -650.1% | 184.4% |
| 每股收益（稀释后） | $-3.88 | $0.12 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ALBASTH
| Q4 25 | $1.4B | $950.5M | ||
| Q3 25 | $1.3B | $956.0M | ||
| Q2 25 | $1.3B | $654.8M | ||
| Q1 25 | $1.1B | $620.4M | ||
| Q4 24 | $1.2B | $665.2M | ||
| Q3 24 | $1.4B | $478.7M | ||
| Q2 24 | $1.4B | $486.3M | ||
| Q1 24 | $1.4B | $404.4M |
净利润ALBASTH
| Q4 25 | $-414.2M | $6.6M | ||
| Q3 25 | $-160.7M | $373.0K | ||
| Q2 25 | $22.9M | $9.4M | ||
| Q1 25 | $41.3M | $6.7M | ||
| Q4 24 | $75.3M | $-7.8M | ||
| Q3 24 | $-1.1B | $16.1M | ||
| Q2 24 | $-188.2M | $19.2M | ||
| Q1 24 | $2.4M | $14.8M |
毛利率ALBASTH
| Q4 25 | 13.9% | — | ||
| Q3 25 | 9.0% | — | ||
| Q2 25 | 14.8% | — | ||
| Q1 25 | 14.5% | — | ||
| Q4 24 | 11.2% | — | ||
| Q3 24 | -7.7% | — | ||
| Q2 24 | -0.7% | — | ||
| Q1 24 | 2.9% | — |
营业利润率ALBASTH
| Q4 25 | -15.2% | 1.9% | ||
| Q3 25 | -16.6% | 2.0% | ||
| Q2 25 | 3.6% | 3.1% | ||
| Q1 25 | 1.8% | 3.3% | ||
| Q4 24 | 0.4% | 0.1% | ||
| Q3 24 | -81.9% | 5.9% | ||
| Q2 24 | -34.4% | 6.2% | ||
| Q1 24 | -13.2% | 7.5% |
净利率ALBASTH
| Q4 25 | -29.0% | 0.7% | ||
| Q3 25 | -12.3% | 0.0% | ||
| Q2 25 | 1.7% | 1.4% | ||
| Q1 25 | 3.8% | 1.1% | ||
| Q4 24 | 6.1% | -1.2% | ||
| Q3 24 | -78.9% | 3.4% | ||
| Q2 24 | -13.2% | 3.9% | ||
| Q1 24 | 0.2% | 3.7% |
每股收益（稀释后）ALBASTH
| Q4 25 | $-3.88 | $0.12 | ||
| Q3 25 | $-1.72 | $0.01 | ||
| Q2 25 | $-0.16 | $0.19 | ||
| Q1 25 | $0.00 | $0.14 | ||
| Q4 24 | $0.29 | $-0.14 | ||
| Q3 24 | $-9.45 | $0.33 | ||
| Q2 24 | $-1.96 | $0.40 | ||
| Q1 24 | $-0.08 | $0.31 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $429.5M |
| 总债务越低越好 | $3.2B | — |
| 股东权益账面价值 | $9.5B | $779.3M |
| 总资产 | $16.4B | $2.2B |
| 负债/权益比越低杠杆越低 | 0.33× | — |
8季度趋势，按日历期对齐
现金及短期投资ALBASTH
| Q4 25 | — | $429.5M | ||
| Q3 25 | $1.9B | $463.4M | ||
| Q2 25 | $1.8B | $342.1M | ||
| Q1 25 | $1.5B | $260.9M | ||
| Q4 24 | $1.2B | $290.8M | ||
| Q3 24 | $1.7B | $350.3M | ||
| Q2 24 | $1.8B | $327.7M | ||
| Q1 24 | $2.1B | $337.3M |
总债务ALBASTH
| Q4 25 | $3.2B | — | ||
| Q3 25 | $3.6B | — | ||
| Q2 25 | $3.6B | — | ||
| Q1 25 | $3.5B | — | ||
| Q4 24 | $3.5B | — | ||
| Q3 24 | $3.6B | — | ||
| Q2 24 | $3.5B | — | ||
| Q1 24 | $3.5B | — |
股东权益ALBASTH
| Q4 25 | $9.5B | $779.3M | ||
| Q3 25 | $10.0B | $775.5M | ||
| Q2 25 | $10.2B | $765.5M | ||
| Q1 25 | $10.0B | $745.4M | ||
| Q4 24 | $10.0B | $712.7M | ||
| Q3 24 | $10.2B | $704.6M | ||
| Q2 24 | $11.2B | $678.9M | ||
| Q1 24 | $11.5B | $653.5M |
总资产ALBASTH
| Q4 25 | $16.4B | $2.2B | ||
| Q3 25 | $17.1B | $2.2B | ||
| Q2 25 | $17.3B | $1.4B | ||
| Q1 25 | $17.0B | $1.3B | ||
| Q4 24 | $16.6B | $1.4B | ||
| Q3 24 | $17.5B | $1.3B | ||
| Q2 24 | $18.4B | $1.3B | ||
| Q1 24 | $19.0B | $1.2B |
负债/权益比ALBASTH
| Q4 25 | 0.33× | — | ||
| Q3 25 | 0.36× | — | ||
| Q2 25 | 0.35× | — | ||
| Q1 25 | 0.35× | — | ||
| Q4 24 | 0.35× | — | ||
| Q3 24 | 0.35× | — | ||
| Q2 24 | 0.31× | — | ||
| Q1 24 | 0.31× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $388.5M | $-2.9M |
| 自由现金流经营现金流 - 资本支出 | $233.1M | $-6.0M |
| 自由现金流率自由现金流/营收 | 16.3% | -0.6% |
| 资本支出强度资本支出/营收 | 10.9% | 0.3% |
| 现金转化率经营现金流/净利润 | — | -0.44× |
| 过去12个月自由现金流最近4个季度 | $692.5M | $104.5M |
8季度趋势，按日历期对齐
经营现金流ALBASTH
| Q4 25 | $388.5M | $-2.9M | ||
| Q3 25 | $355.6M | $10.0M | ||
| Q2 25 | $-7.2M | $90.9M | ||
| Q1 25 | $545.4M | $16.6M | ||
| Q4 24 | $674.0K | $-10.9M | ||
| Q3 24 | $240.5M | $34.0M | ||
| Q2 24 | $362.9M | $23.2M | ||
| Q1 24 | $98.0M | $6.0M |
自由现金流ALBASTH
| Q4 25 | $233.1M | $-6.0M | ||
| Q3 25 | $223.4M | $7.4M | ||
| Q2 25 | $-126.8M | $89.5M | ||
| Q1 25 | $362.8M | $13.6M | ||
| Q4 24 | $-355.1M | $-13.5M | ||
| Q3 24 | $-62.6M | $31.7M | ||
| Q2 24 | $-84.7M | $20.4M | ||
| Q1 24 | $-481.4M | $5.6M |
自由现金流率ALBASTH
| Q4 25 | 16.3% | -0.6% | ||
| Q3 25 | 17.1% | 0.8% | ||
| Q2 25 | -9.5% | 13.7% | ||
| Q1 25 | 33.7% | 2.2% | ||
| Q4 24 | -28.8% | -2.0% | ||
| Q3 24 | -4.6% | 6.6% | ||
| Q2 24 | -5.9% | 4.2% | ||
| Q1 24 | -35.4% | 1.4% |
资本支出强度ALBASTH
| Q4 25 | 10.9% | 0.3% | ||
| Q3 25 | 10.1% | 0.3% | ||
| Q2 25 | 9.0% | 0.2% | ||
| Q1 25 | 17.0% | 0.5% | ||
| Q4 24 | 28.9% | 0.4% | ||
| Q3 24 | 22.4% | 0.5% | ||
| Q2 24 | 31.3% | 0.6% | ||
| Q1 24 | 42.6% | 0.1% |
现金转化率ALBASTH
| Q4 25 | — | -0.44× | ||
| Q3 25 | — | 26.69× | ||
| Q2 25 | -0.31× | 9.65× | ||
| Q1 25 | 13.19× | 2.48× | ||
| Q4 24 | 0.01× | — | ||
| Q3 24 | — | 2.11× | ||
| Q2 24 | — | 1.21× | ||
| Q1 24 | 40.01× | 0.40× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ALB
| Energy Storage | $759.1M | 53% |
| Specialties | $348.9M | 24% |
| Ketjen | $320.1M | 22% |
ASTH
| Medicare | $542.4M | 57% |
| Commercial | $99.1M | 10% |
| Care Delivery | $92.1M | 10% |
| Care Enablement | $78.9M | 8% |
| Other Third Parties | $58.0M | 6% |
| Health Care Patient Service | $39.8M | 4% |
| Health Care Other | $25.5M | 3% |
| Other | $12.1M | 1% |
| Management Service | $10.3M | 1% |
